STATEMENT: Vireo Health of New York CEO Ari Hoffnung responds to Health Department marijuana impact assessment
The following statement can be attributed to Ari Hoffnung, Chief Executive Officer of Vireo Health of New York, one of only 10 organizations licensed in the state to grow, cultivate, manufacture and sell medical cannabis:
“I agree with the conclusions drawn in the state Department of Health’s marijuana legalization impact assessment. Legalization will not only help reduce opioid deaths and discrimination against people of color but also bring substantial tax revenue to the state. It’s time to end the war on drugs and create an environment in which New York patients and adult consumers have safe and legal access to marijuana. Moreover, while not the first state to legalize marijuana, I am confident that New York has the necessary human capital – in the form of manufacturing, marketing and finance talent – to emerge as one of the largest and most influential regulated marijuana markets in the world.”
About Vireo Health of New York
Vireo Health of New York is a physician-led company dedicated to providing best-in-class cannabis-based medications and compassionate care. The Company is a proven leader in the field of medical marijuana. In December 2015, Vireo’s products became the first to be certified Kosher by the Orthodox Union. In addition to brick-and-mortar dispensary locations, Vireo launched the first medical marijuana home delivery service in the New York City area, now available throughout New York City, Westchester, Rockland, Nassau and parts of Suffolk County. For more information, visit https://vireohealth.com/ny/.